The Institute for Molecular Bioscience (IMB) and the Queensland Brain Institute (QBI) seek an outstanding candidate for a Group Leader appointed jointly between the two Institutes.
The Institute for Molecular Bioscience (IMB) is a multidisciplinary research institute of The University of Queensland, Brisbane, Australia. We emphasise high-quality fundamental research and its translation into medical and/or biotechnological outcomes. IMB is equipped with excellent facilities including next-generation sequencing, bioinformatics, data management & computing, proteomics, microscopy & imaging, zebrafish and mouse models, chemistry and drug discovery platforms.

Established in 2003, the Queensland Brain Institute (QBI) is one of the largest neuroscience institutes in the world. It is home to more than 450 researchers, including 34 group leaders, working across a range of disciplines, all dedicated to discovering the fundamental mechanisms regulating development and function in the healthy and diseased brain. These findings are then applied to the development of new therapeutic approaches to prevent and/or restore loss of function in diseases of the nervous system, such as Alzheimer’s and other dementias, stroke, motor neuron disease, anxiety and depression.

The John Trivett Senior Research Fellow in Brain Cancer is funded by the Cure Brain Cancer Foundation, the largest fundraising body for brain cancer research in Australia. The Cure Brain Cancer Foundation’s mission is to accelerate new treatments for brain cancer patients and increase five-year survival to 50% within 10 years. This prestigious Fellowship, the John Trivett Senior Research Fellow in Brain Cancer, has been funded to help meet Cure Brain Cancer’s objective to support the creation and implementation of a collaborative, international and multi-disciplinary brain cancer research community. The multi-disciplinary QBI and IMB collaboration, in conjunction with both Institutes’ outstanding local and international partnerships, is pivotal to the achievement of Cure Brain Cancer’s objective, and is indicative of the research calibre required of the foundation John Trivett Senior Research Fellow in Brain Cancer.

Seeking a visionary research program in Brain Cancer Research
The John Trivett Senior Research Fellow is a joint appointment between IMB and QBI. As a Group Leader you will develop an independent research program funded by competitive grants and fellowships. A substantial five year start-up package is available, as well as a fully funded salary for the Cure Brain Cancer John Trivett Fellow for five years in the first instance but renewable subject to performance.

We seek a visionary researcher with demonstrable achievements in the area of brain cancer and/or neuroscience, or an established cancer researcher who seeks to build an international track record in brain tumour research. Neurosurgical training/qualification would be advantageous.

Selection criteria
• A visionary research program in Brain Cancer that can be supported by competitive external grant and fellowship funding.
• An outstanding national and international profile in the relevant research field; and
• Proven ability to collaborate both internally and externally at the highest levels

The person
We invite applications from established independent researchers who meet the selection criteria. Both IMB and QBI are committed to gender equity and we encourage suitably qualified women to apply.

Remuneration
A five year fixed term renewable contract will be offered and a remuneration package commensurate with the qualifications and experience negotiated for the successful candidate.

Enquiries
For more details about the prestigious John Trivett Fellowship in Brain Cancer please follow the link www.imb.uq.edu.au/John-Trivett-Senior-Research-Fellow-Brain-Cancer

To discuss this position, please contact Professor Brandon Wainwright (Director, IMB) on +61 7 3346 2112 or director@imb.uq.edu.au, or Professor Pankaj Sah (Director, QBI) on +61 7 334 66311 or pankaj.sah@uq.edu.au

Applications should include a cover letter, CV, a 3-page statement of research vision, and the names and contact information of three referees.

Applications should be received by 10 January 2015. …